Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MED compared with MKC: revenue, margins and what each company keeps, and the suppliers and customers both name
MED
Medifast Inc
Change
Mkt cap
Revenue
Revenue
MKC
Mccormick & Co Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
MED
Medifast Inc
vs
MKC
Mccormick & Co Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
MED
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±9.1%
▲
+2.02%
×0.22
Q2 FY26
±10.1%
▲
+34.29%
×3.40
Q1 FY26
±14.3%
▲
+22.48%
×1.57
Feb 18 '26
±8.1%
▼
−0.83%
×0.10
MKC
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±6.4%
▼
−4.87%
×0.77
Q2 FY26
±8.0%
▲
+1.58%
×0.20
= implied
MED realized, solid
MKC realized, hatched
One scale, both sides: full bar = 35%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±7.7%
▼
−6.11%
×0.79
Jan 22 '26
±5.8%
▼
−8.05%
×1.40
MED
Medifast Inc
Change
12.85
▲
+0.93%
· post 12.85
Mkt cap
$143.2M
Revenue
$72M
Q3 FY26
Revenue
$386M
FY25
MKC
Mccormick & Co Inc
Change
48.44
▼
−3.24%
· post 48.44
Closed
Nov 6 '26
Mkt cap
$13.0B
Revenue
$2.0B
Q3 FY26
Revenue
$6.8B
FY25
vs
Compare
Closed
Nov 6 '26
MED
Medifast Inc
vs
MKC
Mccormick & Co Inc
12.85
▲
+0.93%
post 12.85
Price
48.44
▼
−3.24%
post 48.44
$143.2M
Mkt cap
$13.0B
Q3 FY26
$72M
Revenue
$2.0B
Q3 FY26
FY25
$386M
Revenue
$6.8B
FY25
Change
Change
MED
12.85
▲
+0.93%
vs
MKC
48.44
▼
−3.24%
Closed
Nov 6 '26